Nanomedicine Market to Grow at a CAGR of 13.6% by 2030 | Increase the adoption of nanomedicine in the healthcare sector

Reports and data

Massive adoption of nanomedicine in drug and delivery systems owing to increasing technological advancements is driving the revenue growth of nanomedicine market

NEW YORK CITY, NEW YORK, USA, July 1, 2022 / — The Global nanomedicine market The size is expected to reach USD 779.99 billion in 2030 and register a CAGR of 13.6% over the forecast period, according to the latest report from Reports and Data. The increasing precision of technologies used in the healthcare sector and the wide-scale application of nanotechnology in the treatment and diagnosis of various diseases are driving the revenue growth of the nanomedicine market.

Nanomedicine is composed of nanoscale materials such as biocompatible nanoparticles and nanorobots, which can effectively control, prevent, monitor, treat and diagnose diseases. Nanomedicine plays a vital role in the development of advanced and innovative drugs due to its revolutionary small size, and is designed to deliver better outcomes and reduce side effects from standard therapies, such as chemotherapy and radiation therapy. Nanomedicine can also be designed to help immune cells and subsequently eliminate or decrease the number of infected cells in the body.

Nanomedicine may aid in the treatment of cancer, due to its ability to improve anti-cancer immunity and the efficacy of immunotherapy. According to the World Health Organization (WHO), in 2020 nearly 10 million people died of cancer worldwide, making it one of the leading causes of death worldwide. Since nanomedicine has the potential to treat cancer, investments in the nanomedicine market have been exponential in recent times.

Nanotechnology is effective in tissue regeneration to recreate nanoscale features of tissues that can direct cell adhesion, migration and differentiation. In addition, nanomedicine can treat bone, muscle, cardiovascular and nerve tissue diseases.

Click the link for a sample copy of the report: @

Key Players – Abbott, General Electric (GE), Arrowhead Pharmaceuticals, Brigham and Women’s Hospital, Nanospectra Biosciences, AMAG Pharmaceuticals, Celgene Corporation, Leadiant Biosciences, Inc., Pfizer Inc. and Sanofi

Some highlights of the report

In September 2020, Clene Nanomedicine Inc., an American company involved in the development of a potential therapeutic nanocatalyst for the treatment of neurodegenerative diseases with antiviral applications, announced a merger with Tottenham Acquisition I Limited. The merger will advance Clene’s CNM-Au8 into Phase 2 and 3 clinical studies. CNM-Au8 aims to develop a treatment for neurogenic diseases such as Parkinson’s disease.
The nanoparticle segment accounted for the largest share of revenue in 2020. Cancer cells can be identified and treated using nanoparticles, and they also enable the detection of diseases at an early stage.
Therapeutic segment accounted for a significantly large revenue share in 2020 and is expected to register a rapid revenue growth rate during the forecast period. Therapeutics is a rapidly evolving area of ​​nanomedicine that encompasses tissue engineering, transplantation, cell biology and regeneration.
The oncology segment accounted for the largest revenue share in 2020 and is expected to register a rapid revenue growth rate over the forecast period as nanomedicine is increasingly used in cancer treatment. Nanomedicine contributes to the creation of highly effective cancer drugs with fewer side effects.
The diagnostics segment accounted for a significantly large revenue share in 2020. Nanoscale particles increase the sensitivity, speed and flexibility of biological tests by measuring the presence or activity of substances. Nanotechnology also enables the testing of relatively smaller volume samples, which is expected to increase its application and drive the growth of the segment over the forecast period.

To learn more about the report @

Nanomolecule Type Outlook (Revenue, USD Billion; 2018-2030)


Product Type Outlook (Revenue, USD Billion; 2018-2030)

Regenerative medicine
In-vitro diagnostics

Application Outlook (Revenue, USD Billion; 2018-2030)

Medication administration
Diagnostic Imaging
Tissue regeneration

Key Regional Markets Covered in the Report:

North America (United States, Canada, Mexico)
Europe (Italy, UK, Germany, France, Rest of Europe)
Asia-Pacific (India, China, Japan, South Korea, Australia, Rest of Asia-Pacific)
Latin America (Chile, Brazil, Argentina, Peru, rest of Latin America)
Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa, Rest of Middle East and Africa)
The Nanomedicine market has been segmented into key regions globally and offers analysis of growth rate, market share, current and emerging trends, production and consumption ratio, industry chain analysis , demand and supply, import and export, revenue contribution and presence. of key players in each region. Country-wise market analysis is offered in the report to better understand the regional spread and progress of the Nanomedicine market.

Request Report Customization @

Frequently asked questions addressed in the report:

What is the estimated market revenue growth over the forecast period?
What are the key factors driving the revenue growth of the Global Nanomedicine Market?
Which regional market is expected to account for the largest revenue share in the global nanomedicine market during the forecast years?
Who are the key players in the global nanomedicine market?
What are the key findings of the SWOT analysis and Porter’s Five Forces market analysis?

About Us:
Reports and Data is a market research and consulting firm that provides syndicated research reports, custom research reports and consulting services. Our solutions are uniquely focused on your goal of locating, targeting and analyzing changes in consumer behavior across demographics, across industries, and helping customers make smarter business decisions. We offer market intelligence research ensuring relevant and factual research across multiple sectors including healthcare, touchpoints, chemicals, commodities and energy. We are constantly updating our search offerings to ensure that our clients are aware of the latest trends existing in the market. Reports and Data has a strong base of experienced analysts from a variety of areas of expertise. Our industry experience and ability to develop a workable solution to any research problem gives our clients the ability to secure an edge over their respective competitors.

Tushar Rajput
Reports and data
write to us here
Visit us on social media:

Previous Characterization of nanofluids by multifractal analysis of a liquid droplet trace
Next Nanoscale 3D Printing Market - 37% Growth Comes from APAC -3D Systems, Stratasys, Nanowerk, Nano Dimension, Nanoscribe GmbH – Indian Defense News